Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation entitled “Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial” published in the August 16, 2016, issue of JAMA,1 Figure 3C is changed to reflect extended data markers in the Kaplan-Meier plot indicating time to event, which were cut off 1 month early, thus underrepresenting the final difference between placebo and the active treatment groups. Additionally, in the online supplement, the legend for eFigure 2 has been changed to reflect the geometric mean of ratio. This article was corrected online.
Incorrect Figures. JAMA. 2017;317(4):442. doi:10.1001/jama.2016.20139
Browse and subscribe to JAMA Network podcasts!
Create a personal account or sign in to: